Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434–5

Aurélie Kamoun; Aurélien de Reyniès; Yves Allory; Gottfrid Sjödahl; A. Gordon Robertson; Roland Seiler; Katherine A. Hoadley; Clarice S. Groeneveld; Hikmat Al-Ahmadie; Woonyoung Choi; Mauro A.A. Castro; Jacqueline Fontugne; Pontus Eriksson; Qianxing Mo; Jordan Kardos; Alexandre Zlotta; Arndt Hartmann; Colin P. Dinney; Joaquim Bellmunt; Thomas Powles; Núria Malats; Keith S. Chan; William Y. Kim; David J. McConkey; Peter C. Black; Lars Dyrskjøt; Mattias Höglund; Seth P. Lerner; Francisco X. Real; François Radvanyi; Mattias Aine; Isabelle Bernard-Pierrot; Bogdan Czerniak; Ewan A. Gibb; Jaegil Kim; David J. Kwiatkowski; Thierry Lebret; Fredrik Liedberg; A. Arlene Siefker-Radtke; Nanor Sirab; Ann Taber; John N. Weinstein

doi:10.1016/j.eururo.2019.12.014

Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434–5

Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, Gottfrid Sjödahl, A. Gordon Robertson, Roland Seiler, Katherine A. Hoadley, Clarice S. Groeneveld, Hikmat Al-Ahmadie, Woonyoung Choi, Mauro A.A. Castro, Jacqueline Fontugne, Pontus Eriksson, Qianxing Mo, Jordan Kardos, Alexandre Zlotta, Arndt Hartmann, Colin P. Dinney, Joaquim Bellmunt, Thomas PowlesNúria Malats, Keith S. Chan, William Y. Kim, David J. McConkey, Peter C. Black, Lars Dyrskjøt, Mattias Höglund, Seth P. Lerner, Francisco X. Real, François Radvanyi, Mattias Aine, Isabelle Bernard-Pierrot, Bogdan Czerniak, Ewan A. Gibb, Jaegil Kim, David J. Kwiatkowski, Thierry Lebret, Fredrik Liedberg, A. Arlene Siefker-Radtke, Nanor Sirab, Ann Taber, John N. Weinstein

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	436-438
Number of pages	3
Journal	European urology
Volume	77
Issue number	4
DOIs	https://doi.org/10.1016/j.eururo.2019.12.014
State	Published - Apr 2020

ASJC Scopus subject areas

Urology

MD Anderson CCSG core facilities

Bioinformatics Shared Resource

Access to Document

10.1016/j.eururo.2019.12.014

Cite this

Kamoun, A., de Reyniès, A., Allory, Y., Sjödahl, G., Robertson, A. G., Seiler, R., Hoadley, K. A., Groeneveld, C. S., Al-Ahmadie, H., Choi, W., Castro, M. A. A., Fontugne, J., Eriksson, P., Mo, Q., Kardos, J., Zlotta, A., Hartmann, A., Dinney, C. P., Bellmunt, J., ... Weinstein, J. N. (2020). Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434–5. European urology, 77(4), 436-438. https://doi.org/10.1016/j.eururo.2019.12.014

Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434–5. / Kamoun, Aurélie; de Reyniès, Aurélien; Allory, Yves et al.
In: European urology, Vol. 77, No. 4, 04.2020, p. 436-438.

Research output: Contribution to journal › Editorial › peer-review

Kamoun, A, de Reyniès, A, Allory, Y, Sjödahl, G, Robertson, AG, Seiler, R, Hoadley, KA, Groeneveld, CS, Al-Ahmadie, H, Choi, W, Castro, MAA, Fontugne, J, Eriksson, P, Mo, Q, Kardos, J, Zlotta, A, Hartmann, A, Dinney, CP, Bellmunt, J, Powles, T, Malats, N, Chan, KS, Kim, WY, McConkey, DJ, Black, PC, Dyrskjøt, L, Höglund, M, Lerner, SP, Real, FX, Radvanyi, F, Aine, M, Bernard-Pierrot, I, Czerniak, B, Gibb, EA, Kim, J, Kwiatkowski, DJ, Lebret, T, Liedberg, F, Siefker-Radtke, AA, Sirab, N, Taber, A & Weinstein, JN 2020, 'Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434–5', European urology, vol. 77, no. 4, pp. 436-438. https://doi.org/10.1016/j.eururo.2019.12.014

@article{bd7da92686bc4a10b9ae6aff6489159a,

title = "Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434–5",

author = "Aur{\'e}lie Kamoun and {de Reyni{\`e}s}, Aur{\'e}lien and Yves Allory and Gottfrid Sj{\"o}dahl and Robertson, {A. Gordon} and Roland Seiler and Hoadley, {Katherine A.} and Groeneveld, {Clarice S.} and Hikmat Al-Ahmadie and Woonyoung Choi and Castro, {Mauro A.A.} and Jacqueline Fontugne and Pontus Eriksson and Qianxing Mo and Jordan Kardos and Alexandre Zlotta and Arndt Hartmann and Dinney, {Colin P.} and Joaquim Bellmunt and Thomas Powles and N{\'u}ria Malats and Chan, {Keith S.} and Kim, {William Y.} and McConkey, {David J.} and Black, {Peter C.} and Lars Dyrskj{\o}t and Mattias H{\"o}glund and Lerner, {Seth P.} and Real, {Francisco X.} and Fran{\c c}ois Radvanyi and Mattias Aine and Isabelle Bernard-Pierrot and Bogdan Czerniak and Gibb, {Ewan A.} and Jaegil Kim and Kwiatkowski, {David J.} and Thierry Lebret and Fredrik Liedberg and Siefker-Radtke, {A. Arlene} and Nanor Sirab and Ann Taber and Weinstein, {John N.}",

note = "Funding Information: Conflicts of interest: Roland Seiler and Peter C. Black share a patent with GenomeDx. Peter C. Black has received in-kind research funding from GenomeDx; is an advisory board member for AbbVie, Asieris, AstraZeneca, Astellas, Bayer, Biosyent, BMS, Janssen, Lilly, Merck, Roche, Sanofi, and Urogen; and has participated in clinical trials with Genentech, Janssen, Ferring, Astellas, Sitka, and MDx Health. Joaquim Bellmunt has received research funding from Takeda, Pfizer, Novartis, and Sanofi-Aventis, and has an advisory role for Genentech, MSD, Pfizer, GSK, BMS, Pierre Fabre, Sanofi-Aventis, Astellas, OncoGenex, and Janssen. Lars Dyrskj{\o}t has received research funding from Natera and Ferring, and has an advisory role for Ferring. David J. McConkey has received research funding from AstraZeneca and is a consultant for Rainier Pharmaceuticals. Seth P. Lerner is a consultant for UroGen and Vaxiion; has received support for a clinical trial from Endo, FKD, Urogen, and Viventia; and is an advisory board member for Ferring, miR Scientific, QED Therapeutics, and UroGen. Yves Allory is an advisory board member of AstraZeneca. The remaining authors have nothing to disclose.",

year = "2020",

month = apr,

doi = "10.1016/j.eururo.2019.12.014",

language = "English (US)",

volume = "77",

pages = "436--438",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "4",

}

TY - JOUR

T1 - Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer

T2 - A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434–5

AU - Kamoun, Aurélie

AU - de Reyniès, Aurélien

AU - Allory, Yves

AU - Sjödahl, Gottfrid

AU - Robertson, A. Gordon

AU - Seiler, Roland

AU - Hoadley, Katherine A.

AU - Groeneveld, Clarice S.

AU - Al-Ahmadie, Hikmat

AU - Choi, Woonyoung

AU - Castro, Mauro A.A.

AU - Fontugne, Jacqueline

AU - Eriksson, Pontus

AU - Mo, Qianxing

AU - Kardos, Jordan

AU - Zlotta, Alexandre

AU - Hartmann, Arndt

AU - Dinney, Colin P.

AU - Bellmunt, Joaquim

AU - Powles, Thomas

AU - Malats, Núria

AU - Chan, Keith S.

AU - Kim, William Y.

AU - McConkey, David J.

AU - Black, Peter C.

AU - Dyrskjøt, Lars

AU - Höglund, Mattias

AU - Lerner, Seth P.

AU - Real, Francisco X.

AU - Radvanyi, François

AU - Aine, Mattias

AU - Bernard-Pierrot, Isabelle

AU - Czerniak, Bogdan

AU - Gibb, Ewan A.

AU - Kim, Jaegil

AU - Kwiatkowski, David J.

AU - Lebret, Thierry

AU - Liedberg, Fredrik

AU - Siefker-Radtke, A. Arlene

AU - Sirab, Nanor

AU - Taber, Ann

AU - Weinstein, John N.

N1 - Funding Information: Conflicts of interest: Roland Seiler and Peter C. Black share a patent with GenomeDx. Peter C. Black has received in-kind research funding from GenomeDx; is an advisory board member for AbbVie, Asieris, AstraZeneca, Astellas, Bayer, Biosyent, BMS, Janssen, Lilly, Merck, Roche, Sanofi, and Urogen; and has participated in clinical trials with Genentech, Janssen, Ferring, Astellas, Sitka, and MDx Health. Joaquim Bellmunt has received research funding from Takeda, Pfizer, Novartis, and Sanofi-Aventis, and has an advisory role for Genentech, MSD, Pfizer, GSK, BMS, Pierre Fabre, Sanofi-Aventis, Astellas, OncoGenex, and Janssen. Lars Dyrskjøt has received research funding from Natera and Ferring, and has an advisory role for Ferring. David J. McConkey has received research funding from AstraZeneca and is a consultant for Rainier Pharmaceuticals. Seth P. Lerner is a consultant for UroGen and Vaxiion; has received support for a clinical trial from Endo, FKD, Urogen, and Viventia; and is an advisory board member for Ferring, miR Scientific, QED Therapeutics, and UroGen. Yves Allory is an advisory board member of AstraZeneca. The remaining authors have nothing to disclose.

PY - 2020/4

Y1 - 2020/4

UR - http://www.scopus.com/inward/record.url?scp=85079035960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079035960&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2019.12.014

DO - 10.1016/j.eururo.2019.12.014

M3 - Editorial

C2 - 32037144

AN - SCOPUS:85079035960

SN - 0302-2838

VL - 77

SP - 436

EP - 438

JO - European urology

JF - European urology

IS - 4

ER -

Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434–5

ASJC Scopus subject areas

MD Anderson CCSG core facilities

Access to Document

Other files and links

Cite this